Health
Restoring enzyme involved in cellular cleanup could reduce inflammation and scarring from liver disease MASH
A team of investigators co-led by Cedars-Sinai Health Sciences University has identified an enzyme that helps prevent the most common form of liver disease from progressing toward liver failure.
AI Summary
A team led by Cedars‑Sinai Health Sciences University identified an enzyme that may stop the most common form of liver disease, metabolic‑associated steatohepatitis (MASH), from advancing to liver failure. The pre‑clinical study, published in *Nature Metabolism*, shows the enzyme helps prevent the inflammation and scarring that drive organ damage. The research could guide new therapies to halt serious liver injury. MASH affects an estimated 100 million people in the United States.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Menopause leaves a fingerprint that may predict dementia riskContinue reading
- Solving Alzheimer's with math? Researcher explores the possibilitiesContinue reading
- New brain tumor test could transform diagnosis and treatmentContinue reading
- CDC vaccine policy recommendations grind to a halt under Health Secretary KennedyContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow